Leaflet WELLBUTRIN SR 150mg prolonged-release film-coated tablets

Indicated for: depression; smoking cessation

Route of administration: oral

Substance: bupropion (antidepressant)

ATC: N06AX12 (Nervous system | Antidepressants | Other antidepressants)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Bupropion is a medication used for the treatment of major depression and as an aid in smoking cessation. It is a dopamine and norepinephrine reuptake inhibitor that helps improve mood and reduce nicotine withdrawal symptoms.

The medication is taken orally, usually once or twice daily, as directed by a doctor. The dosage is adjusted based on the patient's response and the purpose of treatment.

Common side effects include insomnia, dry mouth, nausea, dizziness, and anxiety. In rare cases, more severe adverse effects such as seizures or severe allergic reactions may occur.

Bupropion is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions. Additionally, it is important for patients to strictly adhere to the prescribed dosage to minimize the risk of serious adverse effects.

General data about WELLBUTRIN SR 150mg

  • Substance: bupropion
  • Date of latest medicines list: 01-07-2013
  • Product code: W08424001
  • Concentration: 150mg
  • Pharmaceutical form: prolonged-release film-coated tablets
  • Quantity: 60
  • Product type: Original
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for bupropion

  • 150mg
  • 300mg

Combinations with other substances